|
186 Products |
| 186 Products |
|
1696 Diseases |  |
95004 News |  |
| «12...136137138139140141142143144145146...10651066» |
- COINCIDENCE OR CORRELATION: A DIAGNOSTIC CONUNDRUM--A PATIENT WITH EOSINOPHILIC PNEUMONIA, HYPERSENSITIVITY PNEUMONITIS, AND ADENOCARCINOMA OF THE LUNG (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1492;
- A CASE OF SEVERE HYPOXEMIA DUE TO LUNG INJURY FROM VAPING (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1446;
- PROPIONIBACTERIUM ACNES-ASSOCIATED SARCOIDOSIS: AN UNCOMMON PRESENTATION (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1442;
- A CASE OF HUMAN CHORIONIC GONADOTROPIN (HCG)-INDUCED THYROTOXICOSIS SECONDARY TO CHORIOCARCINOMA WITH INNUMERABLE METASTATIC LESIONS (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1435;
- Idhifa (enasidenib) / BMS, Servier
TAKE MY BREATH AWAY: ENASIDENIB FOR AML RESULTING IN DIFFERENTIATION SYNDROME (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1285;
- ATYPICAL PRESENTATION OF ANTI-MD5A DERMATOMYOSITIS AND RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1255;
- DIFFUSE ALVEOLAR HEMORRHAGE WITH AN UNKNOWN ETIOLOGY (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1248;
- NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME: A TALE OF TWO ETIOLOGIES OF HYPERPYREXIA (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1197;
- LAMOTRIGINE-INDUCED MULTIPLE ORGAN FAILURE (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1193;
- UNMASKING OF ANCA VASCULITIS BY COVID-19 INFECTION (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1191;
- HSV-1 PNEUMONIA IN AIDS PATIENT LEADING TO VENT DEPENDENCY (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1181;
- HIDING IN PLAIN SIGHT: ADRENAL CRISIS PRESENTING AS SEPSIS IN SETTING OF ESTABLISHED ADRENAL INSUFFICIENCY AND IMMUNOTHERAPY USE (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1168;
- PRONE TO INJURY (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1161;
- SMALL BUT MIGHTY: A CASE REPORT OF EPSTEIN-BARR VIRUS ENCEPHALITIS LEADING TO UNUSUAL COMPLICATIONS IN A WELL CONTROLLED HIV + PATIENT (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1154;
- A CURIOUS CASE OF NEUROCYSTICERCOSIS POST BONE-MARROW TRANSPLANT (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1151;
- NOT ALL SYSTEMS ARE A GO: A CASE OF MULTI-SYSTEM CHECKPOINT INHIBITOR TOXICITY (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1147;
- POST-INTUBATION TRACHEAL STENOSIS: AN ACQUIRED PROBLEM IN A PATIENT WITH PREVIOUS COVID-19 INFECTION (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1137;
- A RARE CASE OF ACUTE RESPIRATORY DISTRESS SYNDROME IN A YOUNG ADULT WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND SYSTEMIC EBV-POSITIVE T-CELL LYMPHOMA OF CHILDHOOD (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1130;
- DISSEMINATED HISTOPLASMOSIS LEADING TO HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A RENAL TRANSPLANT RECIPIENT (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1113;
- HOW TO SURVIVE THE (CYTOKINE) STORM (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1104;
- CATS MAY HAVE NINE LIVES, BUT WE DO NOT: A CASE REPORT OF SESPIS SECONDARY TO PASTEURELLA MULTOCIDA (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1089;
- HYPERCALCEMIA, DIFFUSE INFILTRATES, AND COUGH IN A PATIENT WITH MULTIPLE MYELOMA AND CHRONIC KIDNEY DISEASE (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1036;
- COMPLICATIONS OF COVID-19: A TALE OF EXTENSIVE THROMBOSIS, INCLUDING THE CEREBRAL VENOUS SINUS, THE HEART, AND THE LUNGS (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1019;
- PLASMA EXCHANGE TO THE RESCUE: A CASE OF REFRACTORY LUPUS MYOPERICARDITIS (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_988;
- COVID-19-IT'S NOT OVER YET: A CASE OF COVID-19-INDUCED AORTITIS COMPLICATED BY AORTIC DISSECTION (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_954;
- Airsupra (budesonide/salbutamol) / AstraZeneca, Avillion
AS-NEEDED ALBUTEROL (Convention Center Exhibit Hall - Rapid Area 1A) - Aug 4, 2023 - Abstract #CHEST2023CHEST_927;
- Airsupra (budesonide/salbutamol) / AstraZeneca, Avillion
ALBUTEROL (Convention Center Exhibit Hall - Rapid Area 1A) - Aug 4, 2023 - Abstract #CHEST2023CHEST_926;
- CPAP MACHINE NONCOMPLIANCE SECONDARY TO THE FACIAL RASH CAUSED BY 30 YEARS OF NEOPRENE SENSITIZATION (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_923;
- DR (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_922;
- ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS WITHOUT EOSINOPHILIA: A DIAGNOSTIC CHALLENGE (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_920;
- cytarabine / Generic mfg.
CYTARABINE SYNDROME IN A PATIENT UNDERGOING CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA: A CASE REPORT (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_919;
- fulvestrant / Generic mfg.
BRONCHOSPAM FOLLOWING ADMINISTRATION OF FULVESTRANT: A CASE REPORT (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_917;
- efavirenz / Generic mfg.
THE ART OF ANAPHYLAXIS: RARE CASE OF ANAPHYLACTIC REACTION TO EFAVIRENZ (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_916;
- terbinafine HCL / Generic mfg.
WHEN THE CURE BECOMES THE DISEASE: A CASE OF TERBINAFINE USE CAUSING DELAYED-ONSET ANAPHYLACTIC SHOCK (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_914;
- A CASE OF CENTRAL AIRWAY OBSTRUCTION DUE TO INTRATHORACIC PLASMACYTOMA (Convention Center Exhibit Hall - Rapid Area 3A) - Aug 4, 2023 - Abstract #CHEST2023CHEST_789;
- Darzalex (daratumumab) / J&J
DARATUMUMAB-INDUCED INTERSTITIAL LUNG DISEASE: A CASE REPORT (Convention Center Exhibit Hall - Rapid Area 2D) - Aug 4, 2023 - Abstract #CHEST2023CHEST_780;
- Cubicin (daptomycin) / Merck (MSD)
A DEVASTATING DISPLAY OF DAPTOMYCIN-INDUCED LUNG INJURY (Convention Center Exhibit Hall - Rapid Area 2D) - Aug 4, 2023 - Abstract #CHEST2023CHEST_778;
- AN EXACERBATION OF SYSTEMIC CAPILLARY LEAK SYNDROME ASSOCIATED WITH COVID-19 INFECTION (Convention Center Exhibit Hall - Rapid Area 1D) - Aug 4, 2023 - Abstract #CHEST2023CHEST_718;
- HIV-POSITIVE HUMAN HERPES VIRUS (HHV) 8 ASSOCIATED MULTICENTRIC CASTLEMAN DISEASE COMPLICATED BY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) (Convention Center Exhibit Hall - Rapid Area 1D) - Aug 4, 2023 - Abstract #CHEST2023CHEST_713;
- VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION FOR VENTILATOR SPARING THERAPY IN THE MANAGEMENT OF A PATIENT WITH SEVERE REFRACTORY STATUS ASTHMATICUS (Convention Center Exhibit Hall - Rapid Area 1A) - Aug 4, 2023 - Abstract #CHEST2023CHEST_697;
- DIFFUSE IDIOPATHIC PULMONARY CELL HYPERPLASIA DIAGNOSED BY NAVIGATIONAL BRONCHOSCOPY (Convention Center 323B) - Aug 4, 2023 - Abstract #CHEST2023CHEST_394;
- SHORT-ACTING BETA-AGONISTS AND STEROIDS ARE ASSOCIATED WITH THE DEVELOPMENT OF AERODIGESTIVE DISEASE IN PARTICULATE MATTER-EXPOSED FIREFIGHTERS (Convention Center 317A) - Aug 4, 2023 - Abstract #CHEST2023CHEST_303;
- | Venclexta (venetoclax) / Roche, AbbVie, Walter and Eliza Hall Institute
Trial completion date, Trial primary completion date: NCI-2021-09185: Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Aug 4, 2023
P1, N=6, Recruiting, Sponsor: City of Hope Medical Center
Trial completion date: May 2023 --> May 2024 | Trial primary completion date: May 2023 --> May 2024
- | leflunomide / Generic mfg., pomalidomide / Generic mfg.
Trial completion date, Trial primary completion date: Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma (clinicaltrials.gov) - Aug 4, 2023
P2, N=29, Recruiting, Sponsor: City of Hope Medical Center
Trial completion date: May 2023 --> May 2024 | Trial primary completion date: May 2023 --> May 2024 Trial completion date: Jun 2023 --> Jun 2024 | Trial primary completion date: Jun 2023 --> Jun 2024
- || Breztri Aerosphere (budesonide/formoterol fumarate/glycopyrronium) / AstraZeneca
Enrollment closed, Real-world evidence, Patient reported outcomes, Real-world: RECORD: REported Outcomes in COPD With Trixeo in Real worlD (clinicaltrials.gov) - Aug 4, 2023
P=N/A, N=134, Active, not recruiting, Sponsor: AstraZeneca
Trial completion date: Jun 2023 --> Jun 2024 | Trial primary completion date: Jun 2023 --> Jun 2024 Recruiting --> Active, not recruiting
- | dexamethasone / Generic mfg.
Journal: Quantification of 37 glucocorticoids in chicken muscle by UHPLC-Q-Orbitrap-MS with parallel reaction monitoring. (Pubmed Central) - Aug 3, 2023
In application, we found dexamethasone with 6.5 ?g kg and fluorometholone with 3.9 ?g kg in two chicken samples. These findings suggest that the UHPLC-Q-Orbitrap system, in conjunction with the SPE sample preparation method, has great potential as a routine quantification approach for multiple glucocorticoid residues in chicken samples.
- | vamorolone (VBP15) / Santhera
Preclinical, Journal: Vamorolone improves Becker muscular dystrophy and increases dystrophin protein in bmx model mice. (Pubmed Central) - Aug 3, 2023
Intriguingly, vamorolone increases dystrophin protein in both heart and skeletal muscle. These data indicate that vamorolone, nearing approval for Duchenne, shows efficacy in bmx mice and therefore warrants clinical investigation in BMD.
- | dexamethasone / Generic mfg.
Journal: Thiol-Disulfide Exchange Coordinates the Release of Nitric Oxide and Dexamethasone for Synergistic Regulation of Intestinal Microenvironment in Colitis. (Pubmed Central) - Aug 3, 2023
Specifically, the MON-mediated combination of NO and Dex greatly ameliorated intractable colitis compared with 5-aminosalicylic acid, even after delayed treatment. Together, our results reveal a key contribution of synergistic modulation of the intestinal microenvironment in NO-based colitis therapy and introduce thiol-disulfide hybrid nanotherapeutics for the management of inflammatory diseases and cancer.
- || HM15136 / Hanmi
PK/PD data, Journal: Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long-acting glucagon analogue HM15136 in overweight and obese patients with co-morbidities. (Pubmed Central) - Aug 3, 2023
Together, our results reveal a key contribution of synergistic modulation of the intestinal microenvironment in NO-based colitis therapy and introduce thiol-disulfide hybrid nanotherapeutics for the management of inflammatory diseases and cancer. This study of HM15136 provides a preliminary safety and tolerability profile with initial insights into its efficacy profile.
- | hydrocortisone / Generic mfg.
Journal: Sleep quality in patients with non-functioning pituitary adenoma: impact of replacement therapies with an emphasis on the time of hydrocortisone. (Pubmed Central) - Aug 3, 2023
Our study indicated the presence of depression, and a free T4 level in the upper half of the normal range have an impact on the sleep quality of patients with NFPA. The time of hydrocortisone replacement might be important factor for improved sleep quality in patients with secondary adrenal insufficiency.